| Covariate: BPE | Covariate: BPE (limited subset) | Covariate: FGT | Covariate: breast density | ||||
---|---|---|---|---|---|---|---|---|
Log (HR) | p value | Log (HR) | p value | Log (HR) | p value | Log (HR) | p value | |
Hormonal treatment duration | ||||||||
 1–5 years | 1.52 | < .0001 | 1.52 | < .0001 | 1.61 | < .0001 | 3.17 | 0.02 |
 ≥ 6 years | Ref |  | Ref |  | Ref |  | Ref |  |
Number of metastatic lymph nodes | ||||||||
 > 3 | 2.49 | < .0001 | 1.86 | < 0.001 | 2.64 | < .0001 | 3.11 | 0.001 |
 Micro to 3 | 0.62 | 0.08 | 0.44 | 0.29 | 0.79 | 0.03 | 1.52 | 0.06 |
 Non-metastatic | Ref |  | Ref |  | Ref |  | Ref |  |
Diameter | ||||||||
 20–49 mm |  |  | − 0.62 | 0.28 |  |  |  |  |
 > 50 mm |  |  | 1.16 | 0.03 |  |  |  |  |
 Micro to 19 mm |  |  | Ref |  |  |  |  |  |